DDS-06A:
Twice-Daily Acetaminophen

Our Product

We are developing a twice-daily formulation of acetaminophen that is designed to improve convenience and performance. The pharmacokinetic study for our twice-daily tramadol and acetaminophen combination formulation demonstrated that the acetaminophen component of the formulation rapidly achieved blood plasma levels associated with efficacy in the currently-marketed product followed by controlled release characteristics.

Market Opportunity

Sales of adult acetaminophen products in the United States in 2006 exceeded $1.1 billion, representing more than one-third of the over-the-counter (OTC) pain market.

Status

We are currently determining the optimum formulation with which to advance our development program.